LYPLAL1-AS1
- 2 independent labs in 1 country
- Funders: National Natural Science Foundation of China and 4 more
- Humans2
Effects
2Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
LYPLAL1-AS1 inhibits cellular senescence in human cells.
“LYPLAL1-AS1 overexpression attenuated it”
Cellsoverexpressionadipose tissue
Cell & bioscienceApr 21, 2022
LYPLAL1-AS1 prevents cellular senescence in human cells.
“Knockdown of LYPLAL1-AS1 accelerated hADSC senescence”
Cellsknockdownadipose tissue
Cell & bioscienceApr 21, 2022
MIRLET7B
downin human cells1
1 study
MIRLET7B
downin human cells1
LYPLAL1-AS1 inhibits MIRLET7B in human cells.
“LYPLAL1-AS1 bound to the MIRLET7B promoter region and suppressed its transcription activity”
CellsLYPLAL1-AS1 overexpressionadipose tissue
Cell & bioscienceApr 21, 2022
Associations
2Sarcopenic obesity
upin humans1OR 1.15
1 study
Sarcopenic obesity
upin humans1OR 1.15
LYPLAL1-AS1 is associated with sarcopenic obesity in humans (OR 1.15, 95% CI 1.11-1.19).
“Single-variant association analysis identified one locus 1q41 (lead SNP rs1417066, LYPLAL1-AS1, odds ratio [OR] = 1.15, 95% confidence interval [CI] = [1.11-1.19], p = 1.75 × 10-14)”
Humans
Exome-Wide Sequencing Study Identified Genetic Variants Associated With Sarcopenic Obesity
The journals of gerontology. Series A, Biological sciences and medical sciencesJan 25, 2024
Chronological age
downin humans1
1 study
Chronological age
downin humans1
Chronological age is associated with LYPLAL1-AS1 in humans.
“correlated negatively with age”
Humanswhole-blood
Cell & bioscienceApr 21, 2022